Compounds > valine

valine and Hemophilia B

valine has been researched along with Hemophilia B in 7 studies

Research

Studies (7)

Timeframe	Studies, this research(%)	All Research%
pre-1990	2 (28.57)	18.7374
1990's	3 (42.86)	18.2507
2000's	1 (14.29)	29.6817
2010's	1 (14.29)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hamaguchi, N; Kao, CY; Kao, JT; Lin, CN; Lin, SW; Shen, MC; Yang, SJ; Yang, YL	1
Chandy, M; Jayandharan, G; Nair, SC; Shaji, RV; Srivastava, A	1
Kamiya, K; Maekawa, H; Matsuda, M; Miura, N; Naka, H; Nishimura, T; Sugo, T; Umeyama, H; Yamashita, N; Yoshioka, A	1
Bajaj, SP; Birktoft, JJ; Brackmann, HH; Ludwig, M; Olek, K; Sabharwal, AK; Smith, KJ	1
Bloom, AL; Liddell, MB; Lillicrap, DP; Peake, IR; Taylor, SA	1
Fujimura, Y; Fukui, H; Iwanaga, S; Miyata, T; Niinomi, K; Sakai, T; Yamamoto, K; Yoshioka, A	1
Fukui, H; Iwanaga, S; Kawabata, S; Miyata, T; Sugimoto, M; Takahashi, H; Yoshioka, A	1

Other Studies

7 other study(ies) available for valine and Hemophilia B

Article	Year
Characterisation of factor IX with a glycine-to-valine missense mutation at residue 190 in a patient with severe haemophilia B. Thrombosis and haemostasis, 2011, Volume: 105, Issue:4 Topics: Animals; Benzamidines; Factor IX; Gene Transfer Techniques; Glycine; HEK293 Cells; Hemophilia B; Humans; Male; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Mutation, Missense; Protein Binding; Protein Conformation; Protein Stability; Transgenes; Valine	2011
Novel missense mutations in two patients with factor XI deficiency (Val271Leu and Tyr351Ser) and one patient with combined factor XI and factor IX deficiency (Phe349Val). Journal of thrombosis and haemostasis : JTH, 2005, Volume: 3, Issue:4 Topics: Child; Codon; DNA Primers; Exons; Factor IX; Factor XI; Factor XI Deficiency; Female; Genotype; Hemophilia B; Hemorrhage; Humans; Introns; Leucine; Male; Mutation; Mutation, Missense; Phenotype; Phenylalanine; Polymerase Chain Reaction; Serine; Tyrosine; Valine	2005
Molecular defect in factor IX Tokyo: substitution of valine-182 by alanine at position P2' in the second cleavage site by factor XIa resulting in impaired activation. Biochemistry, 1993, Jun-22, Volume: 32, Issue:24 Topics: Adolescent; Alanine; Base Sequence; Blood Coagulation; Computer Simulation; Factor IX; Factor XIa; Hemophilia B; Humans; Male; Models, Molecular; Molecular Sequence Data; Point Mutation; Polymerase Chain Reaction; Valine	1993
Hemophilia B caused by five different nondeletion mutations in the protease domain of factor IX. Blood, 1992, Mar-01, Volume: 79, Issue:5 Topics: Adult; Arginine; Binding Sites; Calcium; Exons; Factor IX; Glutamates; Glutamic Acid; Glutamine; Hemophilia B; Humans; Hydrogen Bonding; Middle Aged; Mutation; Polymerase Chain Reaction; Promoter Regions, Genetic; Protein Conformation; Serine Endopeptidases; Valine	1992
A mutation adjacent to the beta cleavage site of factor IX (valine 182 to leucine) results in mild haemophilia Bm. British journal of haematology, 1990, Volume: 75, Issue:2 Topics: Aged; Blood Coagulation; Factor IX; Factor IXa; Hemophilia B; Humans; Immunoblotting; Male; Mutation; Nucleic Acid Amplification Techniques; Valine	1990
Blood clotting factor IX Kashihara: amino acid substitution of valine-182 by phenylalanine. Journal of biochemistry, 1989, Volume: 105, Issue:5 Topics: Amino Acids; Chromatography, High Pressure Liquid; Factor IX; Hemophilia B; Humans; Hydrolysis; Mutation; Peptide Mapping; Phenylalanine; Trypsin; Valine	1989
Blood clotting factor IX Niigata: substitution of alanine-390 by valine in the catalytic domain. Journal of biochemistry, 1988, Volume: 104, Issue:6 Topics: Alanine; Amino Acid Sequence; Binding Sites; Factor IX; Hemophilia B; Humans; Molecular Sequence Data; Mutation; Peptide Fragments; Valine	1988